Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
5
|
| pubmed:dateCreated |
1977-11-25
|
| pubmed:language |
spa
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0048-766X
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
41
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
290-4
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:829551-Blood Group Incompatibility,
pubmed-meshheading:829551-Coombs' Test,
pubmed-meshheading:829551-Cyclophosphamide,
pubmed-meshheading:829551-Female,
pubmed-meshheading:829551-Humans,
pubmed-meshheading:829551-Infant, Newborn,
pubmed-meshheading:829551-Lactation,
pubmed-meshheading:829551-Lymphocyte Activation,
pubmed-meshheading:829551-Pregnancy,
pubmed-meshheading:829551-Rh-Hr Blood-Group System
|
| pubmed:year |
1976
|
| pubmed:articleTitle |
[Cyclophosphamide in the prevention of sensitization to Rh factor].
|
| pubmed:publicationType |
Journal Article
|